APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,623,059 | +403.0% | 226,684 | +1104.6% | 0.03% | +383.3% |
| Q2 2023 | $1,714,320 | +429.3% | 18,818 | +283.3% | 0.01% | +500.0% |
| Q1 2023 | $323,864 | -87.7% | 4,910 | -90.3% | 0.00% | -83.3% |
| Q4 2022 | $2,628,057 | +125.0% | 50,823 | +96.8% | 0.01% | +200.0% |
| Q2 2022 | $1,168,000 | -58.6% | 25,823 | -53.5% | 0.00% | -33.3% |
| Q1 2022 | $2,822,000 | +65.7% | 55,546 | +54.2% | 0.00% | +200.0% |
| Q4 2021 | $1,703,000 | -51.1% | 36,021 | -65.9% | 0.00% | -75.0% |
| Q3 2021 | $3,486,000 | +7014.3% | 105,752 | +6391.8% | 0.00% | – |
| Q3 2020 | $49,000 | +2350.0% | 1,629 | +1529.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |